# The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice

Michal Hensler, Kristina Bardova, Zuzana Macek Jílková, Walter Wahli, Daniel Metzger, Pierre Chambon, Jan Kopecky, Pavel Flachs

► To cite this version:

Michal Hensler, Kristina Bardova, Zuzana Macek Jílková, Walter Wahli, Daniel Metzger, et al.. The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice. Lipids in Health and Disease, 2011, 10 (1), pp.128. 10.1186/1476-511X-10-128. [hal-04977181](https://hal.science/hal-04977181v1)

HAL Id: hal-04977181

https://hal.science/hal-04977181v1

Submitted on 5 Mar 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

SHORT REPORT

Open Access

# The inhibition of fat cell proliferation by *n*-3 fatty acids in dietary obese mice

Michal Hensler<fnref n="1" />, Kristina Bardova<fnref n="1" />, Zuzana Macek Jilkova<fnref n="1" />, Walter Wahli², Daniel Meztger³, Pierre Chambon³, Jan Kopecky<fnref n="1" /> and Pavel Flachs<fnref n="1" />*

**Abstract**

**Background:** Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) of marine origin exert multiple beneficial effects on health. Our previous study in mice showed that reduction of adiposity by LC n-3 PUFA was associated with both, a shift in adipose tissue metabolism and a decrease in tissue cellularity. The aim of this study was to further characterize the effects of LC n-3 PUFA on fat cell proliferation and differentiation in obese mice.

**Methods:** A model of inducible and reversible lipoatrophy (aP2-Cre-ER<sup>T2</sup> PPARγ<sup>L2/L2</sup> mice) was used, in which the death of mature adipocytes could be achieved by a selective ablation of peroxisome proliferator-activated receptor γ in response to i.p. injection of tamoxifen. Before the injection, obesity was induced in male mice by 8-week- feeding a corn oil-based high-fat diet (cHF) and, subsequently, mice were randomly assigned (day 0) to one of the following groups: (i) mice injected by corn-oil-vehicle only, i.e. "control" mice, and fed cHF; (ii) mice injected by tamoxifen in corn oil, i.e. "mutant" mice, fed cHF; (iii) control mice fed cHF diet with 15% of dietary lipids replaced by LC *n*-3 PUFA concentrate (cHF+F); and (iv) mutant mice fed cHF+F. Blood and tissue samples were collected at days 14 and 42.

**Results:** Mutant mice achieved a maximum weight loss within 10 days post-injection, followed by a compensatory body weight gain, which was significantly faster in the cHF as compared with the cHF+F mutant mice. Also in control mice, body weight gain was depressed in response to dietary LC *n*-3 PUFA. At day 42, body weights in all groups stabilized, with no significant differences in adipocyte size between the groups, although body weight and adiposity was lower in the cHF+F as compared with the cHF mice, with a stronger effect in the mutant than in control mice. Gene expression analysis documented depression of adipocyte maturation during the reconstitution of adipose tissue in the cHF+F mutant mice.

**Conclusion:** Dietary LC *n*-3 PUFA could reduce both hypertrophy and hyperplasia of fat cells *in vivo*. Results are in agreement with the involvement of fat cell turnover in control of adiposity.

**Keywords:** DHA and EPA, fish oil, fat cell turnover

**Background**

Adipose tissue and its secreted products, adipokines, have a major role in the development of obesity-associated metabolic disarrangement including dyslipidaemia and insulin resistance (i.e. the components of metabolic syndrome). Long-chain *n*-3 polyunsaturated fatty acids (LC *n*-3 PUFA), namely eicosapentaenoic acid (EPA; 20:5 n-3) and docosahexaenoic acid (DHA; 22:6 n-3) act

as natural hypolipidemics, reduce risk of cardiovascular disease and could prevent development of obesity and insulin resistance in humans [1]. Also our experiments on mice have demonstrated that substitution of 15% lipids in a corn oil-based high fat diet (cHF) by LC *n*-3 PUFA concentrate (i.e. feeding cHF+F diet, see Methods) prevented dietary induced obesity and associated metabolic disorders [2-4]. The preferential decrease in abdominal adipose tissue growth resulted not only from modulation of metabolism in response to LC *n*-3 PUFA [5], but probably also in part from the inhibition of fat cell proliferation. Quantification of adipose tissue DNA

<footnote>* Correspondence: flachs@biomed.cas.cz</footnote>

<footnote n="1">¹Department of Adipose Tissue Biology, Institute of Physiology Academy of Sciences of the Czech Republic v.v.i., Prague, Czech Republic
Full list of author information is available at the end of the article</footnote>
revealed that the reduction of epididymal fat was asso-
ciated with 34-50% depression of tissue cellularity [2]. *In
vitro*, both EPA and DHA inhibited adipocyte differen-
tiation and lipid droplet formation [6-8] and DHA
induced apoptosis in postconfluent preadipocytes [7].
To further characterize inhibitory effect of LC *n*-3
PUFA on adipose cell proliferation and differentiation *in
vivo*, and to learn more about the role of fat cell turn-
over in the control of adiposity [9], we used mouse
transgenic model of inducible and reversible lipoatrophy
(aP2-Cre-ER**T2** PPARγ**L2/L2**). In this model, death of
mature brown and white adipocytes is achieved by selec-
tive ablation of peroxisome proliferator-activated recep-
tor γ (PPARγ) using the tamoxifen-dependent Cre-ER**T2**
recombination system [10]. PPARγ is essential for survi-
val of mature adipocyte and deletion of PPARγ causes
adipocyte death, triggers an inflammatory reaction and
promotes proliferation and differentiation of preadipo-
cytes into new adipocyte expressing PPARγ [10]. Our
results document that LC *n*-3 PUFA slow down com-
pensatory adipose tissue growth and adipocyte prolifera-
tion after the transgenically-induced transient
lipoatrophy and they also support the notion [9] that fat
cell turnover is involved in the control of adipose tissue
mass.

**Methods**

Animals and experimental design

Adipose tissue specific PPARγ conditional knock out
mice (aP2-Cre-ER<sup>T2</sup> PPARγ<sup>L2/L2</sup>) were used [10]. In this
transgenic model, PPARγ can be selectively ablated in
mature adipocytes by the conditional Cre-ER<sup>T2</sup> Cre
recombinase whose activity depends on tamoxifen
administration [10]. At 4 weeks of age, male mice were
weaned onto a standard laboratory chow (Chow; lipid
content ~3.4% wt/wt; extruded R/M-H diet; Ssniff
Spezialdiäten, Soest, Germany) and maintained at 22°C
on a 12 h light-dark cycle with free access to food and
water. Starting at 3 months of age, mice were fed a corn
oil based high-fat diet (cHF; lipid content ~35% wt/wt),
and at 5 months of age (day 0; see Figure 1) the animals
were randomly assigned to one of the following groups:
(i) premutant aP2-Cre-ER<sup>T2</sup> PPARγ<sup>L2/L2</sup> mice, intraperi-
toneally twice injected by 100 µl of corn oil at day 0 and
day 1, hereafter named **control PPARγ<sup>ad+/+</sup>** mice,
which were fed cHF diet; (ii) aP2-Cre-ER<sup>T2</sup> PPARγ<sup>L-/L-</sup>
mice intraperitoneally twice injected by 1 mg tamoxifen
in 100 µl of corn oil at day 0 and day 1, and hereafter
named **mutant PPARγ<sup>ad-/</sup>** mice, which were fed cHF
diet; (iii) control PPARγ<sup>ad+/+</sup> mice fed cHF diet supple-
mented with LC *n*-3 PUFA concentrate (product EPAX
1050 TG (46% DHA, 14% EPA), EPAX, a.s., Aalesund,
Norway) replacing 15% of dietary lipids (cHF+F diet);
and (iv) mutant PPARγ<sup>ad-/</sup> mice fed cHF+F diet.

Samples were collected for various analyses at day 14 and at day 42. Fresh rations of food were distributed every second day, food consumption and body weights were recorded. Mice were sacrificed by cervical dislocation in random fed state (between 8 a.m. and 10 a.m.), and EDTA-plasma and selected tissues were collected for various analyses. Several independent experiments were performed, in accordance with the guidelines of the Institute of Physiology for the use and care of laboratory animals.

Histological analysis of adipose tissue

Epididymal white fat samples were fixed in 4% formalde-
hyde embedded in paraffin and stained with hematoxy-
lin/eosin. Morphometry of adipocytes was performed as
before [11], using NIS-Elements 3.0 AR morphometric
software (Laboratory Imaging, Prague, Czech Republic).
The morphometry data are based on more than 800
cells taken randomly from six different areas per animal.

Quantitative real time PCR

Total RNA isolated using TRI Reagent (Molecular
Research Center, Inc, Cincinnati, OH, USA). Levels of
various transcripts were evaluated using LightCycler 480
II instrument (Roche Diagnostic Ltd., Rotkreuz, Switzer-
land) and LightCycler 480 SYBR Green I Master kit
(Roche Diagnostic Ltd., Mannheim, Germany). PCR
condition were 95°C for 5 min and 45 cycles of 95°C for
10 s, 55-60°C for 10 s and 72°C for 20 s. Specificity of
the amplified PCR product was assessed by performing
a melting curve analysis. Lasergene 7 software (DNAS-
TAR, Inc. Madison, WI, USA) was used to design pri-
mers. The PCR primer pairs were used as in Table 1.
To correct for intersample variation, levels of the tran-
script were normalized using geometrical mean of two
reference genes.

Plasma adiponectin

Adiponectin levels were determined using Western blot-
ting as before [11]. Tris-acetate gradient gel (NuPAGE
3-8%, Invitrogen, Life Technologies, Carlsbad, CA, USA)
was used for division of multimeric forms of adiponectin
in plasma. Primary rabbit anti-mouse polyclonal antibo-
dies (BioVendor, Brno, Czech Republic), followed by
secondary donkey anti-rabbit IgG infrared dye conju-
gated antibodies (IR Dye 800, Rockland, Gilbertsville,
PA, USA) were using. Membranes were scanned using
Odyssey IR imager (Li-Cor Biosciences, Lincoln, NE,
USA).

**Statistical analysis**

All values are presented as mean ± SE. Logarithmic
transformation was used to stabilize variance in cells
when necessary. Data were analyzed by one-way
<figure><img src="image_3.png" /></figure>

<figure><img src="image_4.png" /><figcaption>**Figure 1** Growth characteristics. After 8 weeks of high-fat (cHF) feeding, mice were randomly assigned to one of the following groups: (i) control mice, fed cHF (cHF PPARγad+/+); (ii) mutant mice, fed cHF (cHF PPARγad-/-); (iii) control mice, fed cHF enriched by LC n-3 PUFA (cHF+F PPARγad+/+); and (iv) mutant mice, fed cHF+F (cHF+F PPARγad-/-). Part of mice were killed at day 14, while the remaining mice were killed at day 42. **A** Body weights; **B** Frequency distribution of adipocyte cell surface area in epididymal fat at day 42. Data are means ± SE; n = 10.</figcaption></figure>
<table><caption>Table 1 Gene specific forward and reverse primer sequences used for qRT-PCR</caption><thead><tr><th>Gene</th><th>Forward primer</th><th>Reverse primer</th><th>NCBI accession number</th></tr></thead><tbody><tr><td>Cidec/Fsp27</td><td>GACAAGCCCTTCTCCCTGGTG</td><td>CCATCAGAACAGCGCAAGAAGAGA</td><td>NM_178373.3</td></tr><tr><td>Cox3</td><td>TCATCGTCTCGGAAGTATTTTT</td><td>CCACATAAATCAAGCCCTACTAAT</td><td>NC_005089.1</td></tr><tr><td>Cyph β*</td><td>ACTACGGGCCTGGCTGGGTGAG</td><td>TCATCATTGTCGACTCCGGCA</td><td>NM_011149.2</td></tr><tr><td>Eef2*</td><td>GAAACGCGCAGATGTCCAAAAGTC</td><td>CCTTAGACTTGCAGCCCGGC</td><td>NM_007907.2</td></tr><tr><td>Pgc-1α</td><td>CCCAAAGGATGCGCTCTCGTT</td><td>AATCAAGCCACTACAGACACCGCA</td><td>NM_008904.2</td></tr><tr><td>Pparα</td><td>TGCGCAGCTCGTACAGGTCATCAA</td><td>TAAGACTACCTGCTACCGAAATGGGGG</td><td>NM 011144.6</td></tr><tr><td>Scd-1</td><td>ACTGGGGCTGCTAATCTCTGGGTGTA</td><td>TAACAAACCCACCCCAGAGATAAAGCC</td><td>NM_009127.4</td></tr></tbody></table>

Cidec/Fsp27 - cell death-inducing DFFA-like effector c; Cox3 - cytochrome c oxidase subunit III; Cyph β - cyclophilin-β; Eef2 - eukaryotic translation elongation factor 2; Pgc-1α - PPARγ coactivator 1α; Pparα - peroxisome proliferator-activated receptor α; Scd-1 - stearoyl-Coenzyme A desaturase 1; *- reference gene.

ANOVA with Holm-Sidak posthoc test using SigmaStat 3.5 statistical software. Comparisons were judged to be significant at $p \le 0.05$.

## Results

After 8 weeks of cHF feeding, obese mice (body weight 36.9 ± 0.4 g) were randomly assigned to one of the four experimental groups (day 0; see Methods and Figure 1). In accordance with the previous study on this transgenic model [10], temporary controlled PPARγ ablation caused a transient body weight loss reflecting changes in body fat content. Mutant PPARγ<sup>ad/-</sup> mice (i.e., mice injected by tamoxifen in corn oil) achieved a maximum weight loss within 10 days post-injection, independent of diet. Also control PPARγ<sup>ad</sup><sup>+/+</sup> mice showed a small reduction of body weight, reflecting the stress associated with the corn oil (without tamoxifen) injection. Afterward, all mice started to gain body weight with a different dynamics in various groups. Thus, (i) the cHF mice gained body weight much faster than the cHF+F mice, (ii) at 6 weeks after the injection, when body weights stabilized in a group-specific manner, body weights of the cHF mice were bigger as compared with the cHF+F mice; and (iii) the dissociation in final body weights in response to the presence/absence of LC n-3 PUFA in the diet was more apparent in the mutant as compared with the control mice. Therefore, the mutant mice showed the highest final body weights when fed cHF diet, and the highest reduction in body weight gain when fed cHF+F diet (Figure 1A and Table 2). In any period post-injection, food consumption was not affected by either dietary LC n-3 PUFA or genotype (not shown). The weights of interscapular brown fat, dorsolumbar subcutaneous and epididymal white fat were significantly reduced in mutant mice killed at day 14 (Table 2). At day 42, there were no differences between control and mutant mice within same diets, while cHF+F diet became the main force of reduction of adiposity. In accordance with its effect on body weight gain, the cHF+F diet prevented white fat depot growths between

day 14 and day 42 more effectively in the mutant as compared with control mice (Table 2).

Histological and morphometric analysis of epididymal fat was performed to characterize effect of PPARγ ablation on tissue morphology in the model of dietary obese mice. At day 14, mean size of adipocytes was smaller in mutant as compared with control mice, and it was decreased further in response to dietary LC n-3 PUFA, resulting in the smallest adipocytes in the cHF+F mutant mice (Table 2). Importantly, at day 42, mean size of adipocytes was similar in all the groups (Table 2), and also distribution of fat cell sizes was not significantly affected by either diet, or the transient genetic ablation of PPARγ (Figure 1B).

Expression of selected genes was quantified in epididymal fat (Figure 2). At day 14, compared to cHF control mice, a marked down-regulation of *Scd-1* was found in remaining groups. At day 42, only dietary LC n-3 PUFA diminished *Scd-1* expression independently on genotype. Genes connected to lipid metabolism, *Pparα*, *Cox3* and *Cidec* (*Fsp27*), were transiently down-regulated in the mutant as compared with control mice at day 14 only. Dietary LC n-3 PUFA induced expression of these genes at both time points, with the strongest effects elicited in the mutant mice in response to the longer treatment.

Plasma levels of total adiponectin and of its biological active high molecular weight (HMW) form, which is implicated in enhancement of insulin sensitivity [12], were lower in mutant as compared with control mice at day 14. Latter on, total and HMW adiponectin level were similar in both control and mutant mice, with a tendency to be higher in the mutant mice (Table 2). In accordance with our previous findings showing induction of adiponectin by LC n-3 PUFA [3,13], adiponectin levels were higher in the cHF+F as compared with the cHF mice, in both control and mutant mice, even at day 14 (Table 2).

## Discussion

Adipose tissue belongs to the most flexible tissues in the body, because it is rapidly remodeled by hyperplasia and
<table><caption>Table 2 Body weight, fat depots weight, adipocyte size and plasma adiponectin</caption><thead><tr><th rowspan="2"></th><th colspan="2">PPARγ<sup>ad+/+</sup></th><th colspan="2">PPARγ<sup>ad-/</sup></th></tr><tr><th>cHF</th><th>cHF+F</th><th>cHF</th><th>cHF+F</th></tr></thead><tbody><tr><td><strong>Final body weight (g)</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>Day 42</td><td>44.1 ± 2.1</td><td>42.2 ± 1.8</td><td>44.9 ± 1.9</td><td>41.5 ± 2<sup>c</sup></td></tr><tr><td><strong>Epididymal fat (mg)</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>Day 14</td><td>1607 ± 210</td><td>1369 ± 165</td><td>1169 ± 184<sup>a</sup></td><td>1180 ± 28<sup>a</sup></td></tr><tr><td>Day 42</td><td>2934 ± 292</td><td>2391 ± 191<sup>a</sup></td><td>2892 ± 354</td><td>2378 ± 261<sup>a,c</sup></td></tr><tr><td><strong>Size of adipocytes (μm<sup>2</sup>)</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>Day 14</td><td>4397 ± 518</td><td>3381 ± 285<sup>a</sup></td><td>3471 ± 422<sup>a</sup></td><td>3126 ± 323<sup>a,b</sup></td></tr><tr><td>Day 42</td><td>3232 ± 267</td><td>2653 ± 139</td><td>3182 ± 323</td><td>2964 ± 273</td></tr><tr><td><strong>Subcutaneous fat (mg)</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>Day 14</td><td>479 ± 59</td><td>395 ± 39</td><td>319 ± 37<sup>a</sup></td><td>332 ± 37<sup>a</sup></td></tr><tr><td>Day 42</td><td>686 ± 64</td><td>542 ± 59</td><td>656 ± 73</td><td>463 ± 74<sup>a,c</sup></td></tr><tr><td><strong>Interscapular brown fat (mg)</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>Day 14</td><td>147 ± 17</td><td>124 ± 11</td><td>123 ± 13<sup>a</sup></td><td>121 ± 8<sup>a</sup></td></tr><tr><td>Day 42</td><td>190 ± 23</td><td>159 ± 13</td><td>179 ± 15</td><td>150 ± 3</td></tr><tr><td><strong>Adiponectin (A.U.)</strong></td><td></td><td></td><td></td><td></td></tr><tr><td>Day 14</td><td></td><td></td><td></td><td></td></tr><tr><td>HMW</td><td>0.70 ± 0.06</td><td>0.79 ± 0.06</td><td>0.52 ± 0.03<sup>a</sup></td><td>0.50 ± 0.04<sup>a,b</sup></td></tr><tr><td>MMW</td><td>0.79 ± 0.04</td><td>0.82 ± 0.03</td><td>0.51 ± 0.04<sup>a</sup></td><td>0.57 ± 0.02<sup>b</sup></td></tr><tr><td>LMW</td><td>0.01 ± 0.00</td><td>0.01 ± 0.00</td><td>0.01 ± 0.00</td><td>0.01 ± 0.00</td></tr><tr><td>Total</td><td>1.49 ± 0.10</td><td>1.62 ± 0.08</td><td>1.04 ± 0.06<sup>a,b</sup></td><td>1.12 ± 0.06<sup>a,b</sup></td></tr><tr><td>Day 42</td><td></td><td></td><td></td><td></td></tr><tr><td>HMW</td><td>0.54 ± 0.04</td><td>0.96 ± 0.10<sup>a</sup></td><td>0.66 ± 0.07</td><td>1.06 ± 0.11<sup>a,c</sup></td></tr><tr><td>MMW</td><td>0.53 ± 0.02</td><td>0.66 ± 0.05</td><td>0.58 ± 0.04</td><td>0.75 ± 0.05<sup>a,c</sup></td></tr><tr><td>LMW</td><td>0.01 ± 0.0</td><td>0.02 ± 0.0</td><td>0.02 ± 0.0</td><td>0.02 ± 0.0</td></tr><tr><td>Total</td><td>1.09 ± 0.06</td><td>1.64 ± 0.15<sup>a</sup></td><td>1.25 ± 0.10</td><td>1.82 ± 0.14<sup>a,c</sup></td></tr></tbody></table>

A.U., arbitrary units; HMW, high molecular weight adiponectin; MMW, medium molecular weight adiponectin; LMW, low molecular weight adiponectin; data are means ± SE; n = 10; a, b, c - significant differences compared to cHF PPARγ<sup>ad+/+</sup>, cHF+F PPARγ<sup>ad+/+</sup> and cHF PPARγ<sup>ad-/</sup>, respectively.

hypertrophy of adipocytes, depending on energy fluxes. Fat cell turnover might contribute to determination of adiposity [9]. However, the mechanisms, which are involved in setting the turnover and their links to energy balance, remain to be established. Enormous plasticity of adipose tissue was also documented by our results. In agreement with the first study on this transgenic model [10], as well as other model of reversible lipoatrophy [14], 6 weeks after tamoxifen injection, adipose tissue from mutant mice appeared histologically identical to untreated mice, indicating complete tissue regeneration. The global, robust return of fat mass was confirmed by progressive body weight gain, especially in mutant mice fed cHF. The death fat cells are replaced by newly differentiated adipocytes originated from endogenous preadipocytes. The histological changes of epididymal fat

depot from mice fed cHF were mirrored by changes of transcript levels for genes encoding *Scd-1*, *Cidec* (*FSP27*), and *Cox3*. As already described, the above genes are activated during adipocyte differentiation and maturation [15-17]. Similarly, plasma level of adiponectin was associated with the reduction of fat mass in the mutant mice compared to controls at day 14. Thus, similarly as in the transgenic mice fed chow diet [10], also in the dietary obese mice studied here, the transgenically-induced lipoatrophy was fully reversible within approximately 6 weeks after the PPARγ ablation.

Based on our previous results suggesting that the anti-obesity effect LC *n*-3 PUFA could be, at least in part, explained by the prevention of fat cell proliferation during high-fat diet-feeding, we have challenged both control and the transgenic mice by dietary LC *n*-3 PUFA.
<figure><img src="image_5.png" /></figure>

Indeed, the cHF+F diet treatment decreased body weight gain in both control and mutant mice. At both time points analyzed (day 14 and day 42), total body weight, as well as weights of adipose depots were the lowest in the mutant mice fed cHF+F diet. Nevertheless, when body weights stabilized in a group-specific manner, by the end of the treatment at 6 weeks, body weights were affected more by the diet than by the transient genetic ablation. Equal size of adipocytes in all the groups at the end of the treatment, suggest (i) similar number of adipoctyes in epididymal fat within the same type of diet; (ii) existence of mechanisms, which tend to stabilize fat cell number via controlling fat cell turnover; and (iii) tuning of these hypothetical mechanisms by LC *n*-3 PUFA or their metabolites (see below).

In accordance with our already published data show-
ing stimulation of mitochondrial biogenesis and

β-oxidation [5] in white adipose tissue in response to dietary LC *n*-3 PUFA, feeding cHF+F diet induced *Pparα* and *Cox3* expression in control mice. At day 14, tamoxifen-induced-lipoatrophy in mutant mice was associated with lower expression of the above genes and interfered also with the LC *n*-3 PUFA effects. At day 42, expression of *Pparα* and *Cox3* was strongly induced by dietary LC *n*-3 PUFA while no effect of tamoxifen injection was found. Furthermore, qRT-PCR analysis shown identical pattern of *Cidec* expression, i. e. significant reduction by tamoxifen treatment in con- trol mice at day 14 and marked induction by LC *n*-3 PUFA at day 42 with the highest level in the mutant cHF+F mice.

Our results document that dietary LC *n*-3 PUFA could decrease adiposity in obese mice by a mechanism, which depends on counteraction of both, differentiation and proliferation of adipose cells. One possible mechanism involves the changes in fatty acid composition of cellular membranes, and hence, altered formation of PUFA-derived active metabolites like as eicosanoids [1,6,18,19]. The anti-proliferative effect may be involved in the decreased adiposity of pups born to rat dams that fed diets supplemented by *n*-3 fatty acids during gestation and sucking (reviewed in ref. [20]). It has been hypothesized that LC *n*-3 PUFA are involved in the anti-obesity effect of breast-feeding [21]. Importantly, our results support the notion [9] that adiposity is closely linked to the control of fat cell turnover and that mechanisms could exist, which control fat cell proliferation independent of energy balance.

Abbreviations

cHF: corn oil-based high fat diet; cHF+F: cHF diet supplemented with LC *n*-3 PUFA concentrate (15% of dietary lipids); DHA: docosahexaenoic acid; EPA: eicosapentaenoic acid; PPAR-α (-γ): peroxisome proliferator activated receptor-α (-γ); LC *n*-3 PUFA: long-chain *n*-3 polyunsaturated fatty acids.

Acknowledgements

This work was supported by the Czech Science Foundation (301/11/0226). MH was also supported by CSF PhD project (305/08/H037). The authors declare no conflict of interest.

Author details

¹Department of Adipose Tissue Biology, Institute of Physiology Academy of Sciences of the Czech Republic v.v.i., Prague, Czech Republic. ²Center for Integrative Genomics, National Research Center Frontiers in Genetics, University of Lausanne, Lausanne, Switzerland. ³Department of Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, Illkirch, France.

Authors' contributions

MH performed the most of experiments and statistical analysis, contributed to writing of the manuscript; ZMJ and KB performed the histological analysis; WW, DM and PC created aP2-Cre-ER<sup>T2</sup> PPARγ<sup>L2/L2</sup> transgenic murine model, participated in coordination of the study and revising the manuscript; JK participated in the design and coordination of the study and contributed to writing of the manuscript; DM and PC participated in the design and coordination of the study; PF performed initial animal experiments, participated in design and coordination of the study and
drafted the manuscript. All authors read and approved the final version of
the manuscript.

**Competing interests**

The author declares that they have no competing interests.

Received: 21 June 2011 Accepted: 2 August 2011

Published: 2 August 2011

**References**

1. Flachs P, Rossmeisl M, Bryhn M, Kopecky J: Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. *Clinical Sciences* 2009, **116**:1-16.

2. Ruzickova J, Rossmeisl M, Prazak T, Flachs P, Sponarova J, Vecka M, Tvrzicka E, Bryhn M, Kopecky J: Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. *Lipids* 2004, **39**:1177-1185.

3. Jelenik T, Rossmeisl M, Kuda O, Jilkova ZM, Medrikova D, Kus V, Hensler M, Janovska P, Miksić I, Baranowski M, Gorski J, Hebrand S, Jensen TE, Flachs P, Hawley S, Viollet B, Kopecky J: AMP-activated protein kinase α2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids. *Diabetes* 2010, **59**:2737-2746.

4. Kopecky J, Rossmeisl M, Flachs P, Kuda O, Brauner P, Jilkova Z, Stankova B, Tvrzicka E, Bryhn M: n-3 PUFA: bioavailability and modulation of adipose tissue function. *Proc Nutr Soc* 2009, **68**:361-369.

5. Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, Franssen-van Hal NL, Ruzickova J, Sponarova J, Drahota Z, Vlcek C, Keijer J, Houstek J, Kopecky J: Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. *Diabetologia* 2005, **48**:2365-2375.

6. Danesch U, Weber PC, Sellmayer A: Differential effects of n-6 and n-3 polyunsaturated fatty acids on cell growth and early gene expression in Swiss 3T3 fibroblasts. *J Cell Physiol* 1996, **168**:618-624.

7. Kim HK, Della-Fera M, Lin J, Baile CA: Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. *J Nutr* 2006, **136**:2965-2969.

8. Manickam E, Sinclair AJ, Cameron-Smith D: Suppressive actions of eicosapentaenoic acid on lipid droplet formation in 3T3-L1 adipocytes. *Lipids Health Dis* 2010, **9**:57.

9. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P: Dynamics of fat cell turnover in humans. *Nature* 2008, **453**:783-787.

10. Imai T, Takakuwa R, Marchand S, Dentz E, Bornert JM, Messaddeq N, Wendling O, Mark M, Desvergne B, Wahli W, Chambon P, Metzger D: Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse. *Proc Natl Acad Sci USA* 2004, **101**:4543-4547.

11. Medrikova D, Macek JZ, Bardova K, Janovska P, Rossmeisl M, Kopecky J: Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control. *Int J Obes*.

12. Kuda O, Jelenik T, Jilkova Z, Flachs P, Rossmeisl M, Hensler M, Kazdova L, Ogston N, Baranowski M, Gorski J, Janovska P, Kus V, Polak J, Mohamed-Ali V, Burcelin R, Cinti S, Bryhn M, Kopecky J: n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. *Diabetologia* 2009, **52**:941-951.

13. Flachs P, Mohamed-Ali V, Horakova O, Rossmeisl M, Hosseinzadeh-Attar MJ, Hensler M, Ruzickova J, Kopecky J: Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed high-fat diet. *Diabetologia* 2006, **49**:394-397.

14. Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, Roth KA, Kitsis RN, Scherer PE: Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. *Nat Med* 2005, **11**:797-803.

15. Kim YC, Gomez FE, Fox BG, Ntambi JM: Differential regulation of the stearoyl-CoA desaturase genes by thiazolidinediones in 3T3-L1 adipocytes. *J Lipid Res* 2000, **41**:1310-1316.

16. Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, Mizunoya W, Inoue K, Kitazawa R, Kitazawa S, Matsuki Y, Hiramatsu R, Masubuchi S, Omachi A, Kimura K, Saito M, Amo T, Ohta S, Yamaguchi T, Osumi T,

Cheng J, Fujimoto T, Nakao H, Nakao K, Aiba A, Okamura H, Fushiki T, Kasuga M: FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. *J Clin Invest* 2008, **118**:2808-2821.

17. Wilson-Fritch L, Burkart A, Bell G, Mendelson K, Leszyk J, Nicoloro S, Czech M, Corvera S: Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. *Mol Cell Biol* 2003, **23**:1085-1094.

18. Madsen L, Petersen RK, Kristiansen K: Regulation of adipocyte differentiation and function by polyunsaturated fatty acids. *Biochim Biophys Acta* 2005, **1740**:266-286.

19. Flachs P, Ruhl R, Hensler M, Janovská P, Zouhar P, Kus V, Macek JZ, Papp E, Kuda O, Svobodova M, Rossmeisl M, Tsenov G, Mohamed-Ali V, Kopecky J: Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. *Diabetologia*.

20. Ailhaud G, Massiera F, Weill P, Legrand P, Alessandri JM, Guesnet P: Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. *Prog Lipid Res* 2006, **45**:203-236.

21. Arenz S, Ruckerl R, Koletzko B, Von Kries R: Breast-feeding and childhood obesity-a systematic review. *Int J Obes Relat Metab Disord* 2004, **28**:1247-1256.

doi:10.1186/1476-511X-10-128

Cite this article as: Hensler et al.: The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice. *Lipids in Health and Disease* 2011 **10**:128.

Submit your next manuscript to BioMed Central and take full advantage of:

* Convenient online submission

* Thorough peer review

* No space constraints or color figure charges

* Immediate publication on acceptance

* Inclusion in PubMed, CAS, Scopus and Google Scholar

* Research which is freely available for redistribution

Submit your manuscript at
www.biomedcentral.com/submit

BioMed Central